In MM, Sp1 expression and its DNA binding activity have also been demonstrated to be upregulated; inhibition of Sp1 expression using Sp1 siRNA markedly suppressed MM cell growth and induced apoptosis, suggesting Sp1 as a novel therapeutic target for MM [7]. The gene discussed is SP1; the disease is Miyoshi myopathy.